Status:
RECRUITING
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Post COVID-19 Condition
Post-COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even afte...
Detailed Description
Over 500 million individuals worldwide have contracted COVID-19. Among those that have 'recovered' from the acute infection, many suffer from post-COVID-19 condition (experiencing 1 or more symptoms 3...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Officially diagnosed with post COVID-19 condition by a healthcare practitioner
- At least three months since SARS-CoV-2 infection
- Symptoms that persist more than 12 weeks:
- Chronic fatigue (must include) along with one of the following symptoms:
- Difficulty thinking or problem solving ('brain fog')
- Stress or anxiety
Exclusion
- Contraindications/medically unfit to receive hyperbaric treatments at an outpatient facility (pneumothorax, in-patients, requiring infusions to maintain hemodynamics, active and unstable coronary disease)
- Patients with cognitive difficulties and/or mental retardation before COVID diagnosis
- History of traumatic brain injury
- Unlikely to comply with follow-up assessments (e.g. no fixed address, plans to move out of town)
- Known pregnancy or planning a pregnancy in women of childbearing age
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06082518
Start Date
January 2 2024
End Date
December 30 2025
Last Update
January 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N3M5